CRFS cases | Controls | |||||
---|---|---|---|---|---|---|
Variable | Laboratory reference range | Mean | SD | Mean | SD | p Value |
Haemoglobin (g/dl) | 12–16 | 12.9 | 0.78 | 12.9 | 0.91 | 0.94 |
White cell count (×109/l) | 4–11 | 5.89 | 1.51 | 6.12 | 2.1 | 0.26 |
Neutrophil (×109/l) | 1.7–8.0 | 3.54 | 1.08 | 4.41 | 4.7 | 0.17 |
Lymphocyte (×109/l) | 1.0–4.0 | 1.84 | 0.71 | 1.80 | 0.68 | 0.79 |
Monocyte (×109/l) | 0.24–1.1 | 0.36 | 0.16 | 0.37 | 0.12 | 0.60 |
Platelet (×109/l) | 150–450 | 274 | 55.5 | 269 | 53.7 | 0.63 |
Sodium (mmol/l) | 135–145 | 139.27 | 2.07 | 139.52 | 2.22 | 0.55 |
Potassium (mmol/l) | 3.5–4.7 | 4.18 | 0.34 | 4.20 | 0.23 | 0.744 |
Urea (mmol/l) | 2.5–8.0 | 5.48 | 1.19 | 5.74 | 1.53 | 0.32 |
Creatinine (µm/l) | 60–110 | 64.10 | 8.29 | 66.59 | 8.20 | 0.13 |
Uncorrected calcium (mmol/l) | 2.18–2.47 | 2.36 | 0.099 | 2.37 | 0.099 | 0.56 |
Adjusted calcium (mmol/l) | NA | 2.38 | 0.085 | 2.40 | 0.085 | 0.31 |
Phosphate (mmol/l) | 0.75–1.50 | 1.12 | 0.15 | 1.08 | 0.20 | 0.24 |
Alkaline phosphatase (IU/l) | 30–100 | 74.07 | 21.86 | 67.58 | 19.56 | 0.12 |
Alanine transaminase (IU/l) | 0–40 | 25.16 | 11.16 | 27.72 | 14.17 | 0.32 |
Bilirubin (µmol/l) | 0–17 | 6.81 | 3.15 | 7.35 | 2.98 | 0.37 |
Albumin (g/l) | 35–48 | 38.67 | 2.90 | 38.56 | 2.06 | 0.83 |
GGT (IU/l) | 0–30 | 29.33 | 23.54 | 30.49 | 24.92 | 0.81 |
TSH (mU/l) | 0.4–4.0 | 2.63 | 3.31 | 3.25 | 5.05 | 0.50 |
Free T4 (pmol/l) | 12–24 | 13.36 | 4.17 | 13.04 | 3.14 | 0.67 |
Magnesium (mmol/l) | 0.74–1.03 | 0.86 | 0.68 | 0.86 | 0.08 | 0.74 |
CRFS, cancer-related fatigue syndrome; GGT, gamma-glutamyl transpeptidase; TSH, thyroid stimulating hormone.